Metraipolis › archive › dc_8b18e684649e

Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study — Europe PMC PMID:41496421

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41496421
DOI
10.1016/j.breast.2025.104672
License (as archived)
solo-consultazione
Archived
2026-11-07T17:58:46.779Z
SHA-256 of the archived text
777c624f525fc93ef289310875d3a321393f467cf4a200fd94908eefc6ae0a20
Stable URL of this page
https://metraipolis.com/documento/dc_8b18e684649e

How to cite

Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study — Europe PMC PMID:41496421 — Europe PMC (en), https://europepmc.org/article/MED/41496421 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8b18e684649e (Metraipolis archive dc_8b18e684649e, sha256 777c624f525fc93ef289310875d3a321393f467cf4a200fd94908eefc6ae0a20)
BibTeX
@misc{dc8b18e684649e,
  title = {Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study — Europe PMC PMID:41496421},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41496421},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8b18e684649e; sha256 777c624f525fc93ef289310875d3a321393f467cf4a200fd94908eefc6ae0a20},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41496421. Agents can read the archived copy with the MCP tool read_document.